Print
Email
Print Edition StoriesThursday, July 9, 2009
Lieber takes CFO reins at Xcellerex
By Mass High Tech staff
MHT's Galen Moore: Hiring trends and opportunities
MHT's Marc Songini: Technology to keep seniors healthy
MHT's Michelle Lang: Local tech execs tackle the Boston Marathon
Xcellerex Inc., a privately held provider of manufacturing systems for biotherapeutics and vaccines, has named Jonathan Lieber as its chief financial officer.
Lieber worked previously as senior vice president, chief financial officer and treasurer at Altus Pharmaceuticals Inc., where he helped the company in raising $250 million over three funds, including a $110 million initial public offering. His position was cut as part of a 75 percent cut of staff positions in January. Prior to Altus, he served as vice president of SG Cowen’s Healthcare Investment Banking Group.
Lieber graduated from New York University with a master’s degree in business administration and from Boston University with a bachelor’s degree.
Marlborough-based Xcellerex uses the company’s single-use, disposable component technology to form its FlexFactory modular turnkey bioproduction technology.
The company announced in June that its FlexFactory line had been adopted by Crucell NV, an independent vaccine manufacturing company based in The Netherlands.
Xcellerex last received funding, its Series C round, in 2007 with an investment of $31 million. Prior to that, a $20 million second round of financing spurred the company’s shift in strategy toward selling disposable manufacturing technology to other companies.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
